Markovic Filip,Hochmair Maximilian,Mueser Nino,Fabikan Hannah,Rodriguez Vania Mikaela,Janzic Urska,Stjepanovic Mihailo I,Kontic Milica Dj (2025) The Efficacy of First-Line Pembrolizumab Monotherapy in Patients with Metastatic NSCLC Aged ≥70 Years with High PD-L1 (TPS ≥ 50%) Expression: A Multicenter Real-World Study, CANCERS, vol. 17, br. 13, str. - (Article)